A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension

Completed · Phase 2 · Has a placebo group

Conditions studied: Hypertension

In brief

The purpose of this study is to determine a safe and effective dose of ADX415 for the treatment of hypertension.

Key facts

Study ID

NCT00779181

Run by

Addrenex Pharmaceuticals, Inc.

People needed

80

Starts

2008-10-01

Expected to finish

2008-12-01

Last updated by the study team

2008-12-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild to moderate hypertension
• Age 18-75 years, inclusive

You may not qualify if…

• Clinically significant illnesses or abnormalities upon evaluation
• Current treatment with 3 or more antihypertensive meds
• Presence of Type I or uncontrolled Type II diabetes
• Presence of alcohol or drug abuse

Where it is running

• Study site — Austin, Texas, United States
• Study site — Austin, Texas, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.